German company Bayer has just upped the ante on its offer for US biotech seeds and pesticides maker Monsanto. The inventor of the painkiller Aspirin, said that over the past several weeks, it had “engaged in private talks with Monsanto”. In a press release on Thursday, the company stated, “Bayer has raised its all-cash offer … Continue reading “Bayer To Offer $125 Per Share For Monsanto (MON)”
Biotech & Pharma
Biotech & Pharma
Cyrotherapy Could Be Fatal According to FDA
One of the most popular treatments among athletes and celebrities is cyrotherapy. It involves exposure…
July 6, 2016
Biotech & Pharma
Period Proof Underwear Could Be The New Craze
The feminine hygiene market is worth $15 billion, a whopping number that makes sense as…
July 5, 2016
Biotech & Pharma
Tesaro (TSRO) Shares Double On Cancer Drug Success
You know champagne bottles are being popped open when your cancer drug treatment trial ends…
June 29, 2016
Biotech & Pharma
AstraZeneca (AZN) Battles Crestor Competition
AstraZeneca recently received FDA approval to use Crestor, its blockbuster cholestrol drug, to treat children…
June 29, 2016
Biotech & Pharma
This New Vaccine Could Treat Multiple Sclerosis
Multiple Sclerosis is one of the most severe diseases in the neurodegenartive autoimmune family. Protective…
June 27, 2016
Biotech & Pharma
Ackman’s New Video Has Herbalife (HLF) Shares Popping
Billionaire investor William Ackman has made it no secret that he is against Herbalife, the…
June 21, 2016
Biotech & Pharma
Cat Allergy Sent This Pharma Company Plummeting
British biotech company Circassia Pharmaceuticals sank on Monday after its experimental cat allergy treatment failed…
June 20, 2016
Biotech & Pharma
This Common Cancer Treatment May Disappear
It makes absolutely no sense for an effective cancer treatment to vanish from the market,…
June 16, 2016
Biotech & Pharma
Your Hot Tea Could Cause Cancer
Just when we thought the list couldn't get any longer. One more thing has just…
June 15, 2016
Biotech & Pharma
This New Drug Could Help Psoriasis Sufferers
Between 2 to 4 percent of the population suffers from Psoriasis and those who have…
June 13, 2016
Biotech & Pharma
Cantabio Pharmaceuticals Inc. (CTBO) Targets Alzheimer’s
More than 700,000 seniors are expected to die this year from Alzheimer's disease. It is…
June 8, 2016
Biotech & Pharma
Overdosing On Anti-diarrhea Drugs.. Yeah, It’s A Thing
Most of us realize we are in an epidemic when it comes to overdosing on…
June 8, 2016
Biotech & Pharma
Carl Icahn Gives In To Botox By Buying Stake In Allergan (NYSE: ACT)
Just a decade after it initially hit the market, Botox is one of the most…
May 31, 2016